| |
| |
|
| Insider
Information: |
Klaskin Christine M |
| Relationship: |
Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
209,597 |
|
|
Indirect Shares
|
32 |
|
|
| Direct
Value |
$68,271 |
|
|
|
Indirect Value
|
$14 |
|
|
| Total
Shares |
209,629 |
|
|
| Total
Value |
$68,285 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -75.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
PFO & PAO |
2023-01-05 |
153,937 |
2011-10-26 |
32 |
Premium* |
|
|
American Dg Energy Inc |
ADGE |
Director |
2017-05-23 |
0 |
2014-11-21 |
0 |
Premium* |
|
|
Mink Therapeutics, Inc. |
INKT |
Officer |
2021-10-13 |
55,660 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGEN |
Antigenics Inc |
PFO & PAO |
• – – |
2023-01-05 |
4 |
A |
$2.45 |
$76,670 |
D/D |
31,294 |
153,937 |
0 |
- |
|
| AGEN |
Antigenics Inc |
PFO & PAO |
• – – |
2022-02-02 |
4 |
A |
$2.51 |
$74,263 |
D/D |
29,587 |
122,643 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
TreasurerOfficer |
• – – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,660 |
|
- |
|
| AGEN |
Antigenics Inc |
PFO & PAO |
• – – |
2021-09-10 |
4 |
S |
$6.50 |
$72,280 |
D/D |
(11,120) |
93,056 |
0 |
% |
|
| AGEN |
Antigenics Inc |
PFO & PAO |
• – – |
2021-09-10 |
4 |
OE |
$3.36 |
$55,652 |
D/D |
16,563 |
104,176 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2017-12-12 |
4 |
S |
$3.46 |
$19,418 |
D/D |
(5,610) |
64,333 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2017-10-09 |
4 |
A |
$3.59 |
$37,447 |
D/D |
10,431 |
69,943 |
0 |
- |
|
| ADGE |
American Dg Energy Inc |
Director |
– • – |
2017-05-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,000) |
0 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2017-04-19 |
4 |
A |
$3.39 |
$35,354 |
D/D |
10,429 |
63,245 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2017-04-19 |
4 |
D |
$3.39 |
$12,655 |
D/D |
(3,733) |
59,512 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2016-04-26 |
4/A |
D |
$4.15 |
$14,745 |
D/D |
(3,553) |
52,816 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2016-04-26 |
4/A |
A |
$4.15 |
$43,280 |
D/D |
10,429 |
55,369 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2016-04-26 |
4 |
D |
$4.15 |
$14,596 |
D/D |
(3,517) |
6,808 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2016-04-26 |
4 |
A |
$4.15 |
$42,849 |
D/D |
10,325 |
10,325 |
0 |
- |
|
| ADGE |
American Dg Energy Inc |
Director |
– • – |
2014-11-21 |
4 |
B |
$0.72 |
$715 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2013-01-28 |
4 |
A |
$4.35 |
$1,814 |
D/D |
417 |
23,690 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-10-26 |
4 |
A |
$4.42 |
$1,843 |
D/D |
417 |
23,273 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,660 |
22,856 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2012-07-26 |
4 |
A |
$4.61 |
$1,918 |
D/D |
416 |
21,196 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-06-21 |
4 |
D |
$5.05 |
$19,241 |
D/D |
(3,810) |
20,780 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-06-20 |
4 |
D |
$4.99 |
$18,194 |
D/D |
(3,646) |
24,590 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-06-19 |
4/A |
A |
$5.26 |
$39,219 |
D/D |
7,456 |
28,236 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Finance |
• – – |
2012-06-19 |
4 |
A |
$5.26 |
$109,303 |
D/D |
20,780 |
28,236 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2012-04-26 |
4 |
A |
$6.43 |
$2,681 |
D/D |
417 |
20,780 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP, Finance |
• – – |
2012-03-15 |
4 |
A |
$5.31 |
$10,620 |
D/D |
2,000 |
20,363 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
